WallStreetZenWallStreetZen

NASDAQ: MEDS
Trxade Health Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

MEDS past revenue growth

How has MEDS's revenue growth performed historically?
Company
3.76%
Industry
-1.64%
Market
14.15%
MEDS's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
MEDS's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
MEDS's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

MEDS earnings and revenue history

Current Revenue
$10.5M
Current Earnings
-$3.2M
Current Profit Margin
-30.5%

MEDS Return on Equity

Current Company
-275.1%
Current Industry
-13.5%
Current Market
30.8%
MEDS's Return on Equity (-275.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when MEDS announces earnings.

MEDS Return on Assets

Current Company
-70.5%
Current Industry
-3.5%
MEDS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

MEDS Return on Capital Employed

Current Company
-187.73%
Current Industry
-7.1%
MEDS's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MEDS vs Pharmaceutical Retailer Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
MEDS$10.46M-$2.60M-$3.19M+27.66%N/A
CJJD$158.63M-$609.57k-$3.52M+13.14%N/A
GNLN$114.51M-$99.20M-$110.62M-11.37%N/A
BIMI$10.01M-$20.27M-$20.54M+5.61%N/A
LFLY$47.19M$22.47M$19.05M+1.43%N/A
View Top Pharmaceutical Retailer Stocks

MEDS earnings dates

Next earnings date
Jul 24, 2023

Trxade Health Earnings & Revenue FAQ

What were MEDS's earnings last quarter?

On Invalid Date, Trxade Health (NASDAQ: MEDS) reported Q1 2023 earnings per share (EPS) of -$0.07, up 41.67% year over year. Total Trxade Health earnings for the quarter were -$677.95 thousand. In the same quarter last year, Trxade Health's earnings per share (EPS) was -$0.12.

If you're new to stock investing, here's how to buy Trxade Health stock.

What was MEDS's earnings growth in the past year?

As of Q2 2023, Trxade Health's earnings has grown year over year. Trxade Health's earnings in the past year totalled -$3.19 million.

What is MEDS's earnings date?

Trxade Health's earnings date is Invalid Date. Add MEDS to your watchlist to be reminded of MEDS's next earnings announcement.

What was MEDS's revenue last quarter?

On Invalid Date, Trxade Health (NASDAQ: MEDS) reported Q1 2023 revenue of $2.25 million up 30.63% year over year. In the same quarter last year, Trxade Health's revenue was $3.24 million.

What was MEDS's revenue growth in the past year?

As of Q2 2023, Trxade Health's revenue has grown 3.76% year over year. This is 5.4 percentage points higher than the US Pharmaceutical Retailers industry revenue growth rate of -1.64%. Trxade Health's revenue in the past year totalled $10.46 million.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.